Corrections

Am Fam Physician. 2003;67(5):945

The answer block for the “Clinical Quiz” in the October 1, 2002 issue (page 1348) gave an incorrect answer for Question 4, pertaining to the article “Diagnosis and Treatment of Premenstrual Dysphoric Disorder,” on page 1239. The correct answers to this question are C and D. In addition, the question is Type X, rather than Type A. The corrected question is printed below.

Q4. Which of the following drugs is/are approved by the U.S. Food and Drug Administration for the treatment of premenstrual dysphoric disorder?

A. Citalopram (Celexa).
B. Clomipramine (Anafranil).
C. Fluoxetine (Sarafem).
D. Sertraline (Zoloft).

Continue Reading

More in AFP

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.